Healthcare Advertising in Saudi Arabia and the UAE: SFDA, DHA, Google and ChatGPT Rules in One Checklist (2026)

Most health ads in Saudi Arabia and the UAE need prior approval. In Saudi Arabia, the SFDA must approve ads for devices, over-the-counter medicines and other products it supervises. A public-facing device ad costs SAR 3,000 under rules dated 20 July 2026. UAE health ads need a MOHAP licence or, for medical products, EDE approval. Google blocks prescription-drug and online-pharmacy ads in both countries, and ChatGPT blocks health services ads outside the US.

This checklist summarises public regulator and platform documents as read on 1 October 2026. It is not legal advice; confirm each point with the regulator linked in the table before you spend.

Who approves a health ad in Saudi Arabia?

Two bodies split the work. The Saudi Food and Drug Authority (SFDA) approves ads for the products it supervises before they are published, including medical devices, food and over-the-counter medicines. The Ministry of Health governs what licensed practitioners and health facilities say about themselves. A clinic promoting a device-based treatment answers to both.

The SFDA restated the product rule through the Saudi Press Agency on 28 July 2024. Ad claims must be approved by the Authority, the product must be registered or listed, and the ad cannot contain misleading phrases or language that disparages other products. The public can report violating ads on the unified number 19999.

Prescription medicines sit outside this route entirely. The SFDA’s published procedures for non-prescription medicine ads (version 5) accept applications for non-prescription products only. They also require the approval number on the ad and cap one ad format at three media channels. Online ads must sit on the applicant’s own site, without links to unapproved pages.

Fees for medicine ads are where secondary guides and the regulator part ways. Law-firm summaries cite a single SFDA fee per medicine ad, but we could not confirm that amount on sfda.gov.sa on 1 October 2026. Ask the SFDA Drug Sector for the current fee before you build a budget around it.

The SFDA device rules that changed in July 2026

Medical device advertising runs under SFDA requirement MDS-REQ 8, version 4, dated 20 July 2026. It requires SFDA approval before any device ad is published, whether aimed at laypersons or at healthcare practitioners. Healthcare providers, advertising agencies, media outlets and individual advertisers are all named in its scope.

The MDS-REQ 8 document sets out the working rules a paid media team needs:

• Fees: SAR 3,000 for an ad aimed at laypersons and SAR 6,000 for an ad aimed at health practitioners, through the e-services portal, and fees are non-refundable once submitted.
• Timing: a response within 10 days on the portal track, or within the 35-day marketing authorisation review if the ad is filed inside that application.
• Validity: one year on the portal track, extendable up to five years with the same approval number.
• One format, one application: each advertising format needs its own application, though moving approved content to another listed medium does not.
• Language: Arabic for laypersons, English for practitioners.
• On the ad itself: device name, manufacturer, and the approval number with its QR code. No SFDA logo, no competitor comparisons, no claims the SFDA has not approved.
• Online and social: approval applies to any website or platform targeting laypersons in the Kingdom, wherever it is hosted. Creators need a Mawthooq licence, and the content goes to the SFDA at least 12 hours before it is posted.

The document does not say how the QR-code rule applies to text-only search ads. Ask the SFDA before assuming a Google text ad is exempt.

What Saudi clinics and doctors can say in an ad

Less than most marketing teams assume. Article 10 of the Law of Practicing Healthcare Professions forbids a health practitioner from advertising or promoting himself, directly or through an intermediary, except where the implementing regulation allows it. It also bans titles or specialties the practitioner has not obtained.

The implementing regulation adds that practitioners must refrain from commercial-style advertising that is not based on scientific grounds or that conflicts with professional ethics. Both lines appear in the Ministry of Health’s published text of the law.

The Ministry enforces this against social campaigns. On 18 June 2026 it announced action over synchronised, near-identical posts by several practitioners promoting one facility’s services from their personal accounts. The posts referenced prices, booking and insurance, as Ajel reported. The Ministry said health services advertising must follow the health advertising rules and run through approved channels.

For a paid media plan, facility ads run under the facility’s own licence are the safer format. Doctor-fronted promotion, especially coordinated across personal accounts, carries the highest enforcement risk in Saudi Arabia today.

Who approves a health ad in the UAE?

It depends on what you sell and where you are licensed. Ads for medical products need approval from the Emirates Drug Establishment (EDE), which took that service over from MOHAP. MOHAP issues health advertisement licences through its portal, while Dubai’s DHA and Abu Dhabi’s DoH set content rules for the facilities they license.

MOHAP’s health advertisement licence service runs through UAE PASS, charges a non-refundable application fee, and lists a completion time of 1 to 3 working days. The licence number must appear on the approved material. MOHAP also states that its licence does not exempt the advertiser from other authorities’ requirements. Its transfer notice moves advertising approval for medical products to the EDE.

In Dubai, the DHA’s Standards for Medical Advertisement Content on Social Media require a facility’s official account to show its MOHAP medical advertisement licence number, a rule set out in version 1.1, effective 3 October 2022. Any post naming the facility, including an influencer’s, needs the medical director’s approval. A DHA circular dated 17 August 2026 re-circulated that same version, and press coverage in September 2026 highlighted its ban on words such as “the best”, “100 per cent” and “immediate results” (Gulf News). Our full breakdown of the DHA social media standards covers it line by line.

In Abu Dhabi, the DoH Healthcare Providers Manual requires promotional material to be factually accurate and verifiable on request. It bars guarantees of success, criticism of other providers, and claims about services the facility is not licensed to offer. DoH also runs a TAMM service for logging health advertisements. Separately, creators across the UAE need the UAE Media Council’s Advertiser Permit, mandatory since late October 2025 according to Al Tamimi & Company.

The checklist in one table

Use this table to route each ad before anyone writes copy. The first column names the office that signs off, the second what needs approval first, and the third the claims the documents name most directly. Every row links the document we read on 1 October 2026.

Launching a campaign this quarter? Build my health ad calendar around the approval timelines.

What Google Ads allows for clinics, labs and pharmacies

Google’s healthcare policy does not list clinic, lab or hospital services among its restricted categories, so service ads can run. Prescription drugs are another matter. Saudi Arabia and the UAE are absent from Google’s location lists for prescription drug services, prescription drug keywords and manufacturer ads. Google says unlisted locations do not allow that promotion.

In practice, an online pharmacy or telemedicine service that prescribes cannot be certified to advertise prescription drugs to either country. Pharmaceutical manufacturers face the same wall, since Google allows their prescription drug ads only in Canada, New Zealand and the United States. Its over-the-counter list of 28 countries excludes both Gulf markets as well. Selling prescription drugs without a prescription counts as an egregious violation, which suspends the account without warning.

Cost differs sharply between the two markets, according to the Semrush September 2026 snapshot we pulled on 1 October 2026. “dentist dubai” shows an estimated CPC of $12.21 on 2,900 monthly searches in the UAE database, while “dental clinic” shows $1.32 on 135,000 monthly searches in Saudi Arabia. Even in Dubai, the Arabic query “dental clinic Dubai” shows $3.69. These are Semrush estimates, not live auction prices. Arabic-language queries are shown as English translations.

Those numbers change how approval costs land. In Saudi Arabia, the SAR 3,000 fee for one public-facing device-ad format equals $800 at the riyal peg, or roughly 600 clicks at Semrush’s $1.32 estimate. For a small test, the approval can cost more than the media.

Can a clinic advertise on ChatGPT in the Gulf?

No, not as of 1 October 2026. OpenAI’s ad policy, updated 10 September 2026, calls health services ads outside the US “generally prohibited”. Its approved-advertiser exceptions, covering dental services, hospitals, diagnostics and similar categories, apply only in the US. Saudi Arabia and the UAE opened to advertisers in mid-September 2026, but the health rule applies regardless of country.

OpenAI also keeps ads away from personal health and mental health conversations, so even an eligible wellness brand will not appear next to a symptom question. General wellness products that make no medical claims, such as fitness equipment, can apply. Our companion piece on ChatGPT Ads in Saudi Arabia and the UAE covers the categories that can run today and the minimum budgets.

For a clinic, the useful move on ChatGPT is organic: being the source its answers cite when a patient asks about a test, a procedure or a provider, a route that no ad policy blocks.

Pre-launch checklist for clinics, labs, pharmacies and device brands

Work through these steps before any media is bought. They run in order of lead time, so the slowest approvals start first. Each step maps to a document linked in the table above, which means your compliance lead can check every item against the source rather than against our summary.

1. List every product named or shown in the ad. Each one decides whether the SFDA or the EDE is involved.
2. Confirm each product’s registration. Saudi device ads need a valid marketing authorisation; unregistered or unlisted products cannot be advertised.
3. File the approval per format. One SFDA application per device ad format in Saudi Arabia; a MOHAP health advertisement licence, or EDE approval for medical products, in the UAE.
4. Put the numbers on the creative. SFDA approval number and QR code in Saudi Arabia; MOHAP licence number in the UAE, including on the facility’s social account in Dubai.
5. Strip the banned claims from copy and visuals. Superlatives, guarantees, “100 per cent”, comparisons and anything the regulator has not approved.
6. Check every piece of practitioner content. In Saudi Arabia, keep promotion on the facility’s licence. In Dubai, route posts naming the facility through the medical director.
7. Clear the influencer paperwork before booking anyone. Mawthooq licence, signed contract and SFDA submission 12 hours ahead in Saudi Arabia; Media Council Advertiser Permit in the UAE.
8. Remove prescription drug terms from Google keywords, ads and landing pages targeting either country.
9. Exclude ChatGPT Ads from the health media plan until OpenAI’s policy changes.
10. Diary every approval’s expiry date. SFDA device approvals on the portal track run for one year unless extended.

Our read

Approval time, not media, is the real cost in Gulf health advertising. A Saudi device ad needs up to 10 days of SFDA review and a SAR 3,000 fee per format, and UAE ads need a licence number before they run. We would plan creative around the approval calendar, not the launch date.

We also think health brands overweight paid channels in the Gulf. Google blocks the prescription side, ChatGPT blocks health services entirely, and the remaining ads carry approval overhead per format. In regulated health categories, the organic route is where VOCTOS has published results. Delta Medical Labs reached 1M+ monthly organic visits and 1,186 keywords at #1 in Saudi Arabia in an engagement that began in March 2026, per the Delta Medical Labs case study.

Al Hokail Medical Group reached 27,500 monthly organic visits and 30 keywords at #1 in Google KSA, per the Al Hokail case study. Those are organic search results, not ad results, and they do not predict yours. Our step-by-step healthcare SEO strategy explains the method.

FAQ

Do I need SFDA approval for a Google ad about my Riyadh clinic?

If the ad names or shows a medical device, medicine or health product, yes. MDS-REQ 8 covers healthcare providers and any website or platform targeting laypersons in Saudi Arabia. If the ad promotes only clinic services, the Ministry of Health’s rules on practitioner and facility advertising apply instead, and those still restrict self-promotion.

Why did Google disapprove our online pharmacy ads in Saudi Arabia?

Because Google allows prescription drug services, including online pharmacies, only in a listed set of countries, and neither Saudi Arabia nor the UAE is on it. Google also bars prescription drug terms in keywords and landing pages for unlisted countries. Selling prescription drugs without a prescription can suspend the account without warning.

Can our doctors post about our Dubai clinic on Instagram?

Yes, with conditions set by the DHA social media standard. Under it, any post naming the facility needs the medical director’s approval, and the facility’s official account must show its MOHAP advertisement licence number. The standard, re-circulated by DHA in August 2026, bans claims such as “the best” and “100 per cent”, and before-and-after photos must be unedited.

How long does SFDA approval take for a medical device ad?

Under MDS-REQ 8 version 4, the SFDA responds within 10 days to applications filed through its e-services portal. If the ad is filed inside a marketing authorisation application, the review runs within 35 days. Portal approvals last one year and can be extended up to five years. Each separate ad format needs its own application.

Can a UAE clinic run ads on ChatGPT?

No, because OpenAI’s ad policy, updated 10 September 2026, calls health services ads outside the US “generally prohibited”, and its exceptions for dental, hospital and diagnostic advertisers are US-only. A DHA or DoH licence does not change that. Wellness products with no medical claims can apply, but clinics and labs cannot.

The faster launch is the approved one

The question health marketers usually ask is which platform performs best in the Gulf. The question that decides launch dates is which approvals each ad needs, from whom, and how long they take. Answer that first and the platform choice gets simpler, because Google closes the prescription door and ChatGPT closes the health-service door in both countries.

If your approval numbers are in hand, run Google search for clinic services with the numbers on the creative and the landing page, and keep prescription terms out. If they are not, file the SFDA or MOHAP applications this week and put the waiting time into organic pages that answer patient questions.

Either way, re-read the source documents on the day you file. The SFDA reissued its device advertising rules in July 2026 and the DHA re-circulated its social media standard in August 2026, so a checklist built from memory is already out of date.

Plan my clinic’s paid search around SFDA and MOHAP approvals